Andreas Weiss

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Replacement Therapy

Molecular Docking

Top Venues

Cancer research

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Anirudh Prahallad, Andreas Weiss, Johannes Voshol, Grainne Kerr, Kathleen Sprouffske, Tina Yuan, David A Ruddy, Morgane Meistertzheim, Malika Kazic-Legueux, Tina Kottarathil, Michelle Piquet, Yichen Cao, Laetitia Martinuzzi-Duboc, Alexandra Buhles, Flavia Alder, Salvatore Mannino, Luca Tordella, Laurent Sansregret, Sauveur-Michel Maira, Diana Graus Porta, Carmine Fedele, Saskia M Brachmann
CRISPR screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer. Cancer research (2023)
Edwige L Lorthiois, Marc Gerspacher, Kim S Beyer, Andrea Vaupel, Catherine Leblanc, Rowan Stringer, Andreas Weiss, Rainer Wilcken, Daniel A Guthy, Andreas Lingel, Claudio Bomio, Rainer Machauer, Pascal Rigollier, Johannes Ottl, Dorothee Arz, Pascal Bernet, Gaëlle Desjonqueres, Solene Dussauge, Malika Kazic-Legueux, Marie-Anne Lozac'h, Christophe Mura, Mickaël Sorge, Milen Todorov, Nicolas Warin, Florence Zink, Johannes Voshol, Frederic J Zecri, Richard C Sedrani, Nils Ostermann, Saskia M Brachmann, Simona Cotesta
JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRAS G12C for the Treatment of Solid Tumors. Journal of medicinal chemistry (2022)